Chemoinformaics analysis of Tectorigenin-4-sulphate
| Molecular Weight | 380.33 | nRot | 4 |
| Heavy Atom Molecular Weight | 368.234 | nRig | 20 |
| Exact Molecular Weight | 380.02 | nRing | 3 |
| Solubility: LogS | -2.754 | nHRing | 1 |
| Solubility: LogP | 0.715 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 8 | APOL | 44.8395 |
| nHD | 3 | BPOL | 24.7705 |
| QED | 0.579 |
| Synth | 2.622 |
| Natural Product Likeliness | 1.323 |
| NR-PPAR-gamma | 0.712 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.501 |
| Pgp-sub | 0.001 |
| HIA | 0.334 |
| CACO-2 | -5.152 |
| MDCK | 0.0000103 |
| BBB | 0.002 |
| PPB | 0.993072 |
| VDSS | 0.336 |
| FU | 0.00942583 |
| CYP1A2-inh | 0.692 |
| CYP1A2-sub | 0.763 |
| CYP2c19-inh | 0.099 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.599 |
| CYP2c9-sub | 0.88 |
| CYP2d6-inh | 0.254 |
| CYP2d6-sub | 0.285 |
| CYP3a4-inh | 0.094 |
| CYP3a4-sub | 0.053 |
| CL | 1.224 |
| T12 | 0.292 |
| hERG | 0.03 |
| Ames | 0.007 |
| ROA | 0.474 |
| SkinSen | 0.285 |
| Carcinogencity | 0.86 |
| EI | 0.833 |
| Respiratory | 0.679 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.868732 |